NYSE:PRGO - Perrigo Stock Price, News, & Analysis

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

Perrigo announced a quarterly dividend on Wednesday, August 1st. Shareholders of record on Friday, August 31st will be given a dividend of $0.19 per share on Tuesday, September 18th. This represents a $0.76 dividend on an annualized basis and a yield of 1.04%. The ex-dividend date is Thursday, August 30th. View Perrigo's Dividend History.

Perrigo Company PLC (NYSE:PRGO) released its earnings results on Thursday, August, 9th. The company reported $1.22 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $1.21 by $0.01. The company earned $1.19 billion during the quarter, compared to analysts' expectations of $1.23 billion. Perrigo had a return on equity of 11.92% and a net margin of 4.77%. Perrigo's revenue was down 4.2% compared to the same quarter last year. During the same quarter last year, the company earned $1.22 earnings per share. View Perrigo's Earnings History.

Perrigo is scheduled to release their next quarterly earnings announcement on Thursday, November, 8th 2018. View Earnings Estimates for Perrigo.

Perrigo updated its FY18 earnings guidance on Thursday, August, 9th. The company provided earnings per share (EPS) guidance of $4.75-4.95 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.21.

17 equities research analysts have issued 12-month target prices for Perrigo's shares. Their forecasts range from $67.00 to $117.00. On average, they expect Perrigo's stock price to reach $89.0588 in the next year. This suggests a possible upside of 22.1% from the stock's current price. View Analyst Price Targets for Perrigo.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last year. There are currently 1 sell rating, 10 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Perrigo.

Some companies that are related to Perrigo include ASTELLAS PHARMA/ADR (ALPMY), Takeda Pharmaceutical (TKPYY), Shiseido (SSDOY), Alexion Pharmaceuticals (ALXN), Teva Pharmaceutical Industries (TEVA), Mylan (MYL), BioMarin Pharmaceutical (BMRN), UCB (UCBJF), GRIFOLS S A/S (GRFS), Merck KGaA (MKGAF), Ono Pharmaceutical (OPHLF), Jazz Pharmaceuticals (JAZZ), Nektar Therapeutics (NKTR), Genmab A/S (GNMSF) and Alnylam Pharmaceuticals (ALNY).

Press coverage about PRGO stock has trended somewhat positive this week, according to Accern. The research group identifies positive and negative press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Perrigo earned a media and rumor sentiment score of 0.19 on Accern's scale. They also assigned news coverage about the company an impact score of 46.94 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next several days. View Recent Headlines for Perrigo.

Perrigo's stock is owned by a number of of retail and institutional investors. Top institutional investors include Starboard Value LP (7.34%), BlackRock Inc. (6.38%), FMR LLC (3.73%), Victory Capital Management Inc. (2.02%), Parnassus Investments CA (1.63%) and Manning & Napier Group LLC (1.07%). Company insiders that own Perrigo stock include Gary K Kunkle Jr, Geoffrey M Parker, Herman Morris Jr, Jeffrey C Smith, Jeffrey Needham, John Wesolowski, Judy L Brown, Sharon Kochan, Svend Andersen, Thomas Farrington, Todd W Kingma and Uwe Roehrhoff. View Institutional Ownership Trends for Perrigo.

PRGO stock was sold by a variety of institutional investors in the last quarter, including Standard Life Aberdeen plc, Millennium Management LLC, Systematic Financial Management LP, Migdal Insurance & Financial Holdings Ltd., Fisher Asset Management LLC, Manning & Napier Group LLC, Point72 Asset Management L.P. and Jane Street Group LLC. Company insiders that have sold Perrigo company stock in the last year include Jeffrey Needham, John Wesolowski, Sharon Kochan, Thomas Farrington and Todd W Kingma. View Insider Buying and Selling for Perrigo.

PRGO stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, Renaissance Technologies LLC, Starboard Value LP, Los Angeles Capital Management & Equity Research Inc., Victory Capital Management Inc., Marshall Wace LLP, Harel Insurance Investments & Financial Services Ltd. and Menora Mivtachim Holdings LTD.. Company insiders that have bought Perrigo stock in the last two years include Geoffrey M Parker, Jeffrey C Smith, John Wesolowski, Svend Andersen and Uwe Roehrhoff. View Insider Buying and Selling for Perrigo.

Shares of PRGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of PRGO stock can currently be purchased for approximately $72.96.

Perrigo has a market capitalization of $9.56 billion and generates $4.95 billion in revenue each year. The company earns $119.60 million in net income (profit) each year or $4.93 on an earnings per share basis. Perrigo employs 10,400 workers across the globe.

Perrigo's mailing address is TREASURY BUILDING LOWER GRAND CANAL STREET, DUBLIN L2, 49010. The company can be reached via phone at 353-1709-4000 or via email at [email protected]